Skip to main content
. 2024 May 8;629(8013):878–885. doi: 10.1038/s41586-024-07385-1

Extended Data Fig. 4. Authentic virus neutralization in plaque assays using Vero E6-TMPRSS2-T2A-ACE2 (VAT) cells.

Extended Data Fig. 4

a-c, Plaque assay neutralization of (a) Delta, (b) Omicron BA.1 and (c) Omicron BA.1.1 viruses. Data are represented as the normalized infection of mAb-treated virus to virus treated with control human IgG (Invitrogen). For S309, each point shows one of four technical replicates; all other points show one of two technical replicates at each concentration. Curves are two-parameter (IC50, hill-slope) logistic fits to normalized response. d, IC50 values (ng/ml, “>” indicates IC50 greater than 10,000 ng/mL) show that 2130-1-0104-024, while having only two mutations from COV2-2130, remains potent against BA.1 and suffers a 20-times loss in potency against BA.1.1. 2130-1-0114-112 is strongly potent against all three tested variants. All analysis performed in GraphPad Prism.